相关实验视频

Updated: Jan 16, 2026

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

在帕金森病和阿尔茨海默病细胞模型中,LRRK2-介导的神经炎症诱导的神经功能障碍

Veronica Mutti¹, Giulia Carini¹, Moira Marizzoni²

¹Unit of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.

|September 27, 2025

概括

氨酸丰富的重复激酶2 (LRRK2) 驱动神经炎症,导致神经退行性疾病 (NDs) 中的神经元死亡. 抑制LRRK2激酶活性提供神经保护,并可能限制ND的进展.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
遗传学是一个遗传学.

背景情况:

慢性神经炎症是神经退行性疾病 (NDs) 的关键因素,如帕金森病 (PD) 和阿尔茨海默病 (AD).
氨酸丰富的重复激酶2 (LRRK2) 参与了PD的发病过程,并与神经炎症有关.
在ND中,LRRK2在神经炎症诱导的神经元损伤中的作用需要进一步调查.

研究的目的:

研究LRRK2-介导的神经炎症对神经元功能和PD和AD模型中的存活率的影响.
为了确定LRRK2激酶抑制是否可以减轻神经炎症诱导的神经元损伤.

主要方法:

利用细胞模型与人类诱导的多能干细胞 (hiPSC) 衍生的神经元 (多巴胺基对PD,胆固醇对AD).
暴露在炎症性质介质中的神经元含有用于PD的α-synuclein (α-syn) 预形成纤维素 (pffs) 或用于AD的粉样β (Aβ) _1-42 纤维素.
进行了转录组分析和功能测试,以评估神经炎症和LRRK2的作用,包括测试LRRK2激酶抑制剂.

主要成果:

发现LRRK2-依赖的神经炎症在PD和AD模型中对神经元功能障碍和死亡有显著的贡献.
对LRRK2激酶活性的药理抑制有效地防止了这些对神经元的有害影响.
转录组分析揭示了由LRRK2-介导的神经炎症影响的关键路径.

结论:

LRRK2在中介神经炎症方面发挥着至关重要的作用,这导致神经退行性疾病中神经元损伤.
准LRRK2激酶活性代表了减少神经炎症和保护PD和AD神经元的潜在治疗策略.
通过减轻神经炎症,LRRK2抑制可能提供神经保护性益处,这表明它在治疗神经退行性疾病方面的潜力.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.这是LRRK2 帕金森病是帕金森氏症的一种疾病.这是 hiPSC.神经退行性疾病的神经退行性疾病神经炎症是一种神经炎症.

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...